306 related articles for article (PubMed ID: 27242166)
1. Human T cell responses to Japanese encephalitis virus in health and disease.
Turtle L; Bali T; Buxton G; Chib S; Chan S; Soni M; Hussain M; Isenman H; Fadnis P; Venkataswamy MM; Satishkumar V; Lewthwaite P; Kurioka A; Krishna S; Shankar MV; Ahmed R; Begum A; Ravi V; Desai A; Yoksan S; Fernandez S; Willberg CB; Kloverpris HN; Conlon C; Klenerman P; Satchidanandam V; Solomon T
J Exp Med; 2016 Jun; 213(7):1331-52. PubMed ID: 27242166
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain.
Kumar P; Krishna VD; Sulochana P; Nirmala G; Haridattatreya M; Satchidanandam V
J Gen Virol; 2004 Feb; 85(Pt 2):471-482. PubMed ID: 14769905
[TBL] [Abstract][Full Text] [Related]
3. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273
[TBL] [Abstract][Full Text] [Related]
4. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations.
Kumar P; Uchil PD; Sulochana P; Nirmala G; Chandrashekar R; Haridattatreya M; Satchidanandam V
Arch Virol; 2003 Aug; 148(8):1569-91. PubMed ID: 12898332
[TBL] [Abstract][Full Text] [Related]
5. Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4+ and CD8+ T cells in a healthy Japanese encephalitis virus-endemic cohort.
Kumar P; Sulochana P; Nirmala G; Haridattatreya M; Satchidanandam V
J Gen Virol; 2004 May; 85(Pt 5):1131-1143. PubMed ID: 15105530
[TBL] [Abstract][Full Text] [Related]
6. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
Front Immunol; 2018; 9():2225. PubMed ID: 30327651
[TBL] [Abstract][Full Text] [Related]
7. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
[TBL] [Abstract][Full Text] [Related]
8. Identification of Immune Responses to Japanese Encephalitis Virus Specific T Cell Epitopes.
Pushpakumara PD; Jeewandara C; Wijesinghe A; Gomes L; Ogg GS; Goonasekara CL; Malavige GN
Front Public Health; 2020; 8():19. PubMed ID: 32117854
[No Abstract] [Full Text] [Related]
9. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
[TBL] [Abstract][Full Text] [Related]
10. Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses.
Trobaugh DW; Yang L; Ennis FA; Green S
Eur J Immunol; 2010 May; 40(5):1315-27. PubMed ID: 20213733
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.
Li Y; Counor D; Lu P; Duong V; Yu Y; Deubel V
Virol J; 2012 Jul; 9():135. PubMed ID: 22828206
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses.
Pushpakumara PD; Jeewandara C; Gomes L; Perera Y; Wijewickrama A; Malavige GN; Goonesekara C
PLoS One; 2020; 15(10):e0238609. PubMed ID: 33112881
[TBL] [Abstract][Full Text] [Related]
13. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
14. Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae.
Kumar P; Sulochana P; Nirmala G; Chandrashekar R; Haridattatreya M; Satchidanandam V
J Infect Dis; 2004 Mar; 189(5):880-91. PubMed ID: 14976606
[TBL] [Abstract][Full Text] [Related]
15. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.
Rivino L; Kumaran EA; Jovanovic V; Nadua K; Teo EW; Pang SW; Teo GH; Gan VC; Lye DC; Leo YS; Hanson BJ; Smith KG; Bertoletti A; Kemeny DM; MacAry PA
J Virol; 2013 Mar; 87(5):2693-706. PubMed ID: 23255803
[TBL] [Abstract][Full Text] [Related]
16. Nonstructural protein 1 antibody-based epitope-blocking enzyme-linked immunosorbent assay to differentiate Japanese encephalitis virus from dengue virus infections in humans.
Konishi E; Konishi M
Jpn J Infect Dis; 2011; 64(4):284-91. PubMed ID: 21788702
[TBL] [Abstract][Full Text] [Related]
17. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.
Krishna VD; Rangappa M; Satchidanandam V
J Virol; 2009 May; 83(10):4766-77. PubMed ID: 19264772
[TBL] [Abstract][Full Text] [Related]
19. Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
Turtle L; Brindle HE; Schluter WW; Faragher B; Rayamajhi A; Bohara R; Gurung S; Shakya G; Yoksan S; Dixit S; Rajbhandari R; Paudel B; Adhikari S; Solomon T; Griffiths MJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007269. PubMed ID: 30986252
[TBL] [Abstract][Full Text] [Related]
20. Selective Reactivity of Anti-Japanese Encephalitis Virus NS4B Antibody Towards Different Flaviviruses.
Kaufusi PH; Tseng AC; Kelley JF; Nerurkar VR
Viruses; 2020 Feb; 12(2):. PubMed ID: 32075019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
